Psyence Group Inc.
PSYG
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -48.06% | -4.46% | 59.24% | 233.72% | 1.60% |
| Depreciation & Amortization | -25.00% | -92.06% | -90.36% | -91.38% | -93.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.09% | -24.78% | 55.99% | 264.61% | -50.71% |
| Operating Income | 40.09% | 24.78% | -55.99% | -264.61% | 50.71% |
| Income Before Tax | -969.67% | 98.21% | -913.19% | 691.17% | 158.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -969.67% | 98.21% | -913.19% | 691.17% | 158.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -100.84% | -- | -- | -- |
| Net Income | -969.67% | 93.92% | -913.19% | 691.17% | 158.10% |
| EBIT | 40.09% | 24.78% | -55.99% | -264.61% | 50.71% |
| EBITDA | 40.09% | 23.66% | -59.75% | -283.53% | 50.27% |
| EPS Basic | -737.28% | 94.03% | -889.38% | 658.84% | 152.82% |
| Normalized Basic EPS | -504.88% | -130.27% | -469.27% | -257.53% | 96.58% |
| EPS Diluted | -737.28% | 94.03% | -889.38% | 658.84% | 152.82% |
| Normalized Diluted EPS | -504.88% | -130.27% | -469.27% | -257.53% | 96.58% |
| Average Basic Shares Outstanding | 36.47% | 1.94% | 2.90% | 5.76% | 9.99% |
| Average Diluted Shares Outstanding | 36.47% | 1.94% | 2.90% | 5.76% | 9.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |